All data are based on the daily closing price as of February 20, 2026
s
Suzuken
9987.TSE
40.38 USD
-1.24
-2.98%
Overview
Last close
40.38 usd
Market cap
2.82B usd
52 week high
42.27 usd
52 week low
29.12 usd
Target price
37.14 usd
Valuation
P/E
13.765
Forward P/E
N/A
Price/Sales
0.1769
Price/Book Value
1.047
Enterprise Value
1.32B usd
EV/Revenue
0.0848
EV/EBITDA
3.6209
Key financials
Revenue TTM
15.50B usd
Gross Profit TTM
1.24B usd
EBITDA TTM
320.38M usd
Earnings per Share
2.71 usd
Dividend
0.64 usd
Total assets
8.35B usd
Net debt
-1.11B usd
About
Suzuken Co., Ltd., together with its subsidiaries, primarily engages in the distribution of pharmaceuticals in Japan and internationally. The company operates in four segments: Pharmaceutical Distribution, Healthcare Product Development, Community Healthcare and Nursing Care Support, and Healthcare Related Services. The Pharmaceutical Distribution Business segment purchases ethical drugs, diagnostic agents, medical equipment, medical materials, and medical food products, as well as pharmaceutical and medical equipment manufacturers, and supplies medical institutions, and insurance pharmacies. The Healthcare Product Development segment offers ethical drugs, diagnostic reagents, and medical devices and materials. The Community Healthcare and Nursing Care Support segment provides a range of pharmacy and nursing care services. The Healthcare Related Services segment offers contract distribution for manufacturers and contract distribution of orphan drugs. Suzuken Co., Ltd. was founded in 1932 and is headquartered in Nagoya, Japan.